Pfizer Says Covid Vaccine Safe And Robust For Children Aged 5 To 11
In a news release on Monday, Pfizer said its two-dose vaccine showed a “favorable safety profile and robust neutralizing antibody responses” in the age group. The companies now plan to seek authorization from the U.S Food and Drug Administration to use the vaccine in these children. The Pfizer-BioNTech is already available for anyone aged 12 and over, but many patients are keen to vaccinate hunger children with the highly contagious Delta variant driving a surge in pediatric infections....